unoprostone
Sign in to saveAlso known as RSC021, 13,14-dihydro-15-keto-20-ethyl PGF2α, (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid, (+)-(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)-5-heptenoic acid, 13,14-dihydro-15-keto-20-ethyl PGF2alpha
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.
It was approved by the Food and Drug Administration in 2000.In 2009, Sucampo Pharmaceuticals acquired the rights to the drug in the U.S. and Canada.
Excerpted from Wikipedia’s “unoprostone” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0